Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
PMCID: PMC7902646
When mitochondrial homeostasis and integrity are compromised, it can lead to excessive production of ROS
Cancel at least 72 hours before your next billing date
The phase 2 trial published in The New England Journal of Medicine in 2023 enrolled adults with obesity without type 2 diabetes and demonstrated dose-dependent weight loss of up to 24.2% of body weight at the highest dose over 48 weeks results that attracted considerable scientific and media attention
Conclusion Combining topiramate and Zepbound is possible for many individuals, but it is a clinical decision that must be made by a professional
FDA-approved medications for chronic weight management include GLP-1 receptor agonists (semaglutide injection, liraglutide), combination agents (phentermine/topiramate ER, naltrexone/bupropion ER), and lipase inhibitors (orlistat)
